Clínic Barcelona. Hospital Universitari

Maria Rozman Jurado

Back

senior Consultant

Hospital Clínic – Biomedical Diagnostic CenterPathology

  • Hematological Cytology.
  • Bone marrow histopathology.
  • Hematopathology cytochemistry.
  • Integrated diagnosis in hematopathology
  • Lymphoproliferative disorders: Collaborator of the CLL Genome project of the International Cancer Genome Consortium. Member of the IELSG (International extranodal lymphoma study Group).
  • Acute Myeloid leukemia (AML): Biological markers with prognostic significance. Member of the CETLAM group (catalan group for the study and treatment of AML)
  • Monoclonal Gammopathies. Colaborator of the "Mieloma Group"
  • Myeloproliferative neoplasms: member of the GEFIN (spanish group for philadelphia-negative mieloid neoplasms)
  • Member of the Spanish Group for Myelodysplastic Syndromes
  • Residents teaching: Bone marrow aspirate and byopsy extraction. Hematological Cytology and Bone marrow histopathology interpretation. Haematology resident tutor (mentor of Haematology trainees)2013-15
  • Member of the European Bone Marrow Working Group (EBMWG)of the European Hematopathology Association..
  • Senior Member of the Spanish Group of Haematological Cytology Organizer of accreditated activities.
  • Director/Coordinator of the Hematopathology Seminars of the Clinic Hospital, activity accreditated since 2003.
  • Teaching Collaborator on Haematology, University of Barcelona
  • Array

Other charges

  • Member of the Mortality Comitee

  • Member of the Spanish Group for Haematological Cytology

  • Member of the Board of the Spanish Society of Haematology and Haemotherapy

Recent articles

  • Multilineage Dysplasia is Associated with a Poorer Prognosis in Patients with de novo Acute Myeloid Leukaemia with Intermediate-Risk Cytogenetics and Wild-Type NPM1
    Rozman M, Navarro JT, Arenillas L, Aventín A, Giménez T, Alonso E, Perea G, Camós M, Navarrete M, Tuset E, Florensa L, Millá F, Nomdedéu J, de la Banda E, Díaz-Beyá M, Pratcorona M, Garrido A, Brunet S, Sierra J, and Esteve J. .
    Ann Hematol. 2014;93:1695-1703
  • Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.
    Ferreira PG, Jares P, Rico D, Gómez-López G, Martínez-Trillos A, Villamor N, Ecker S, González-Pérez A, Knowles DG, Monlong J, Johnson R, Quesada V, Djebali S, Papasaikas P, López-Guerra M, Colomer D, Royo C, Cazorla M, Pinyol M, Clot G, Aymerich M, Rozman M, Kulis M, Tamborero D, Gouin A, Blanc J, Gut M, Gut I, Puente XS, Pisano DG, Martin-Subero JI, López-Bigas N, López-Guillermo A, Valencia A, López-Otín C, Campo E, Guigó R..
    Genome Res. 2014;24:212-226
  • Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report.
    Raya JM, Montes-Moreno S, Acevedo A, Ferrández A, Fraga M, García JF, García M, Mayordomo-Aranda E, Menárguez J, Besses C, Calzada R, Rozman M..
    J Clin Pathol. 2014;67:620-625
  • Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
    Broséus J, Alpermann T, Wulfert M, Florensa Brichs L, Jeromin S, Lippert E,Rozman M, Lifermann F, Grossmann V, Haferlach T, Germing U, Luño E, Girodon F, Schnittger S; MPN and MPNr-EuroNet (COST Action BM0902). .
    Leukemia. 2013;27:1826-1831

Academic Qualifications

  • (1991)
  • (1990)
  • (1985)

Biomedical Diagnostic Center (CDB)

Villarroel, 170 · 08036 Barcelona
Tel: +34 93 227 54 64 · Fax: +34 93 227 98 75 · · www.hospitalclinic.org